Edit |   |
---|---|
Antigenic Specificity | ERBB3, Human (Seribantumab biosimilar) |
Clone | Seribantumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ERBB3 Recombinant Antibody (Seribantumab). Seribantumab (INN, development code MM-121) is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Sanofi/Merrimack Pharmaceuticals, Inc. |
Immunogen | n/a |
Other Names | Anti-ERBB3 Recombinant Antibody, Research Grade Seribantumab, Anti-Human ERBB3 Recombinant Antibody(Seribantumab), MM-121, SAR256212, Antibody Drug Analogues, Monoclonal Antibody, YR1300, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1334296-12-6 |
Catalog # | YR1300 |
Price | please inquire |
Order / More Info | ERBB3, Human (Seribantumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |